drugset / Trial / NCT02171780
A Study to Assess Safety, Tolerability and Pharmacokinetics of Single Rising Inhaled Doses of BI 1744 CL in Healthy Male and Female Volunteers
RandomizedParallel-groupDouble-blindTreatment
Summary
To investigate safety, tolerability, and pharmacokinetics of BI 1744 CL
Timeline
- Start
- 2005-02
- Primary completion
- 2005-07
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Olodaterol | Small molecule | 0.5 ug | Inhaled |
| Subject | Olodaterol | Small molecule | 70 ug | Inhaled |
Indications
No indication recorded.